Donations will fund the ongoing development of the Circulating Tumor DNA project which will improve outcomes for those children already diagnosed with cancer. Based upon a normal blood sample, ctDNA can give a window into the progress of the tumor treatment. If a tumor is not responding to a treatment, ctDNA will show this faster than current techniques.
Donations will cover the costs for each child's sample to be researched. ctDNA sampling requires only a simple blood test and can be conducted as often as required. This provides the opportunity for more intensive surveillance and faster clinical response times, at lower cost.
Donations will reduce the need for hospital visits. The technology may also remove barriers to rural communities and ethnic groups who may have poor access to hospital care.